Anticoagulant strategies for the patient with chronic kidney disease.

Law, Jonathan Philip, Pickup, Luke, Townend, Jonathan N and Ferro, Charles J (2020) Anticoagulant strategies for the patient with chronic kidney disease. Clinical medicine (London, England), 20 (2). pp. 151-155. ISSN 1473-4893.

Full text not available from this repository.
Official URL:


Chronic kidney disease (CKD) is a global health problem affecting up to 14% of the adult population in developed countries. On the basis of current guidelines, patients with CKD will often fulfil criteria for both short-term and long-term anticoagulation. Paradoxically, patients with CKD are not only at a higher risk of thrombosis, they are also at increased risk of bleeding. Furthermore, the pharmacokinetics and pharmacodynamics of many anticoagulant therapies are significantly affected by renal dysfunction. In addition, patients with advanced CKD are often systematically excluded from major clinical trials. As such, the decision on whether to anticoagulate or not, and if so with what agent, poses significant challenges. A solid understanding of the condition in question and the available treatments is required to make an informed judgement call. An in-depth appreciation of the advantages and disadvantages of the currently available anticoagulants is a key element in the decision-making process.

Item Type: Article
Subjects: WJ Urogenital system. Urology
Divisions: Emergency Services > Renal
Related URLs:
Depositing User: Mrs Caroline Tranter
Date Deposited: 23 Mar 2020 10:45
Last Modified: 23 Mar 2020 10:45

Actions (login required)

View Item View Item